Protective effect of ischemic preconditioning on hepatic ischemia-reperfusion injury by advancing the expressive phase of survivin in rats

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 6, 2008, Pages 615-620

  Li, Jian Yi ^a   Gu, Xi ^a   Yin, Hong Zhuan ^a   Zhou, Yong ^a   Zhang, Wen Hai ^a   Qin, Yi Min ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shenyang First People's Hospital   (China)

Author keywords

Ischemia reperfusion injury; Ischemic preconditioning; Survivin protein

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MALONALDEHYDE; SURVIVIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LIVER FUNCTION; LIVER ISCHEMIA; LIVER LEVEL; LIVER PROTECTION; MALE; MICROSCOPY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; ISCHEMIC PRECONDITIONING; LIVER; MALE; MALONDIALDEHYDE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 57849165754     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bátkai S, Osei-Hyiaman D, Pan H, El-Assal O, Rajesh M, Mukhopadhyay P, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 2007;21:1788-1800.
2. Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006;79:1881-1894.
3. Husted TL, Lentsch AB. The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury. Curr Pharm Des 2006;12:2867-2873.
4. Okada T, Sawada T, Kubota K. Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model. Transplantation 2007;84:504-510.
5. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007;9:49-89.
6. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006;43:S31-44.
7. Liedtke C, Lambertz D, Schnepel N, Trautwein C. Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-alpha signalling. Apoptosis 2007;12:2259-2270.
8. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007;249:49-60.
9. Ouhtit A, Matrougui K, Bengrine A, Koochekpour S, Zerfaoui M, Yousief Z. Survivin is not only a death encounter but also a survival protein for invading tumor cells. Front Biosci 2007;12:1260-1270.
10. Düsünceli F, Iseri SO, Ercan F, Gedik N, Yegen C, Yegen BC. Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides 2008;29:1216-1222.
11. Alexandrova A, Petrov L, Georgieva A, Kessiova M, Tzvetanova E, Kirkova M, et al. Effect of MG132 on proteasome activity and prooxidant/ antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatol Res 2008;38:393-401.
12. Blei AT. Selection for acute liver failure: have we got it right? Liver Transpl 2005;11:S30-34.
13. Rivo J, Raphael J, Drenger B, Berenshtein E, Chevion M, Gozal Y. Flumazenil mimics whereas midazolam abolishes ischemic preconditioning in a rabbit heart model of ischemia-reperfusion. Anesthesiology 2006;105:65-71.
14. Zhang W, Zhu W, Zhang J, Li N, Li J. Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats. Microsurgery 2008;28:285-290.
15. Shi LB, Huang JH, Han BS. Hypoxia inducible factor-1alpha mediates protective effects of ischemic preconditioning on ECV-304 endothelial cells. World J Gastroenterol 2007;13: 2369-2373.
16. Hahn O, Szijártó A, Lotz G, Schaff Z, Vígváry Z, Váli L, et al. The effect of ischemic preconditioning prior to intraoperative radiotherapy on ischemic and on reperfused rat liver. J Surg Res 2007;142:32-44.
17. Kuboki S, Schuster R, Blanchard J, Pritts TA, Wong HR, Lentsch AB. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice. Am J Physiol Gastrointest Liver Physiol 2007;292:G1141-1149.
18. Mochizuki K, Ohno Y, Kanematsu T, Sakurai-Yamashita Y, Niwa M, Hishikawa Y, et al. Possible protection of sinusoidal endothelial cells by endothelin B receptor during hepatic warm ischemia-reperfusion. Surg Today 2007;37: 460-467.
19. Fischer UM, Antonyan A, Bloch W, Mehlhorn U. Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion. Interact Cardiovasc Thorac Surg 2006;5:531-535.
20. Guimaraes SB, Aragao AA, Santos JM, Kimura Ode S, Barbosa PH, Vasconcelos PR. Oxidative stress induced by torsion of the spermatic cord in young rats. Acta Cir Bras 2007;22:30-33.
21. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/ reperfusion injury in the rat. Stroke 2008;39:2362-2369.
22. Riddle-Taylor E, Nagasaki K, Lopez J, Esquivel CO, Martinez OM, Krams SM. Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury. Transplantation 2007;84:778-785.
23. Mejía C, Navarro S, Llombart-Bosch A. Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation. Histol Histopathol 2007;22:1365-1370.
24. Li R, Boehm AL, Miranda MB, Shangary S, Grandis JR, Johnson DE. Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. Neoplasia 2007;9:801-811.
25. Piekarska A, Kubiak R, Omulecka A, Szymczak W, Piekarski J. Expression of tumour necrosis factor-related apoptosis-inducing ligand and caspase-3 in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C. Histopathology 2007;51:597-604.
26. Moon PD, Koo HN, Jeong HJ, Na HJ, Kim SJ, Hwang GS, et al. Haeamtang induces apoptosis of colon cancer HT-29 cells through activation of caspase-3. Am J Chin Med 2007; 35:897-909.
27. Croci DO, Cogno IS, Vittar NB, Salvatierra E, Trajtenberg F, Podhajcer OL, et al. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. J Cell Biochem 2008.
28. Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006;18:609-615.
29. Vaira V, Lee CW, Goel HL, Bosari S, Languino LR, Altieri DC. Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 2007;26:2678-2684.
30. Blum R, Jacob-Hirsch J, Rechavi G, Kloog Y. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. Md Cancer Ther 2006;5:2337-2347.
31. Tzirogiannis KN, Papadimas GK, Kondyli VG, Kourentzi KT, Demonakou MD, Kyriakou LG, et al. Peliosis hepatis: microscopic and macroscopic type, time pattern, and correlation with liver cell apoptosis in a model of toxic liver injury. Dig Dis Sci 2006;51:1998-2006.
32. Jacotot E, Deniaud A, Borgne-Sanchez A, Touat Z, Briand JP, Le Bras M, et al. Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis. Biochim Biophys Acta 2006;1757:1312-1323.
33. Huang YH, Huang XH, Gui JF, Zhang QY. Mitochondrion-mediated apoptosis induced by Rana grylio virus infection in fish cells. Apoptosis 2007;12:1569-1577.
34. Rajesh KG, Suzuki R, Maeda H, Murio Y, Sasaguri S. 5-HT2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury. Life Sci 2006;79:1749-1755.
35. Ling X, Cheng Q, Black JD, Li F. Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin. J Biol Chem 2007;282:27204-27214.
36. Fukuda S, Kaga S, Sasaki H, Zhan L, Zhu L, Otani H, et al. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol 2004;36:547-559.
37. Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003;9:2683-2692.
38. Ryan BM, Konecny GE, Kahlert S, Wang HJ, Untch M, Meng G, et al. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol 2006;17:597-604.
39. Squadrito F, Altavilla D, Squadrito G, Saitta A, Deodato B, Arlotta M, et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury. J Mol Cell Cardiol 2000;32: 429-440.